Neudle.com: glutamate receptors

Differential
(Click to cross reference)

acute disseminated encephalomyelitis

advances in neurology

adverse drug reaction

alveolar hypoventilation

Alzheimer's disease

Alzheimer's disease, treatment of

AMPA receptor antibodies

AMPA receptors

amphiphysin antibodies

amygdala

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, etiology of

amyotrophic lateral sclerosis, treatment of

anti GQ1b IgG antibody

autoimmune basal ganglia encephalitis

autoimmune cerebellar ataxia

autoimmune disease

autoimmune encephalopathy

autoimmune epilepsy

automobile accidents

autonomic dysfunction

autonomic neuropathy

Babinski sign

baclofen

basal ganglia, lesion of

basal ganglia, lesion, bilateral

bat bite

behavior, combative

behavioral disorder

behavioral disorder, acute

carcinoma of pancreas

CAT scan, chest

CAT scan, emission

CAT scan, emission, abnormal

CAT scan, pelvis

catatonia

celiac disease, adult

central nervous system, infection of

cerebellar ataxia, primary

cerebellar atrophy, primary

cerebellar degeneration

cerebellar lesion

cerebellar peduncle

cerebellitis

cerebellitis, autoimmune

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, gammaglobulin of

cerebrospinal fluid, oligoclonal IgG in

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, mimics

cerebrovascular accident, nonarterial territory

cerebrovascular accident, pathophysiology

cerebrovascular accident, prevention of

cerebrovascular accident, thrombolytic agents in treatment

cerebrovascular accident, time of presentation

children

chorea

choreoathetosis

Clinical Pathologic Conference(C.P.C.)

clonus

cognition

coinfection

collapsin response mediator protein 5 IgG

coma

coma, medically induced

common variable immunodeficiency

complications

confusion

conjugate gaze, forced

contactin associated protein like 2 antibodies

contractures, joint

controversies in neurology

conversion reaction

cortical ribbon sign

creatine phosphokinase(CPK)elevated

degenerative diseases of CNS

delusion

dementia

dementia, reversible

dementia, treatment of

demyelinating disease

depression

dermatomyositis

developmental milestones, loss of

diabetes mellitus

diagnostic criteria

diarrhea

differential diagnosis

diplopia

disability, neurological

DPPX, antibodies, encephalitis

dyskinesia, buccal lingual facial

electroencephalogram, abnormalities of

encephalitis lethargica

encephalitis, autoimmune

encephalitis, brainstem

encephalitis, clinical picture and treatment of

encephalitis, etiology

encephalitis, paraneoplastic

encephalitis, unilateral

encephalitis, unknown etiology

encephalitis, viral

encephalitis, viral-causes of

encephalomyelitis

encephalomyelitis, autoimmune

encephalomyelitis, paraneoplastic

encephalopathy

encephalopathy, Hashimoto's

encephalopathy, progressive

enuresis

epidemiology of neurology

epilepsia partialis continua

Epstein-Barr virus

excitotoxin

extralimbic encephalitis

extreme delta brush

eye movement, disorders of

face, numbness of

faciobrachial dystonic seizure

gamma amino butyric acid

gamma amino butyric acid receptor antibody

gammaglobulin therapy, intravenous

gaze deviation

gaze palsy

gaze palsy, horizontal

gender

GluD2

glutamic acid

glutamic acid decarboxylase, antibody

glycine receptor antibodies

grimacing

Guillain Barre syndrome, variant forms of

gyrus, abnormal

hallucination

hallucination, visual

head injury

headache

hearing loss

hearing loss, bilateral

hemiballismus

hemiparesis

heralding manifestation

herpes simplex encephalitis

herpes simplex encephalitis, atypical

herpes simplex encephalitis, recurrent

herpes simplex virus

hippocampal atrophy

hippocampus

hippocampus, hyperintense

Hodgkin's disease

Hodgkin's disease, neurologic involvement with

hypoxic encephalopathy

imbalance

immune checkpoint inhibitors

immune-related adverse events

immunologic disease

immunology and the nervous system

immunomodulation

immunosuppression

immunosuppressive agents

immunotherapy

inappropriate antidiuretic(A.D.H.)hormone

inborn errors of metabolism, screening

intellectual deterioration

internuclear ophthalmoplegia

internuclear ophthalmoplegia, bilateral

ischemic penumbra

Jakob-Creutzfeldt disease

leg weakness, bilateral

lethargy

leucine rich glioma inactivated 1 antibodies

level of consciousness

level of consciousness, decreased

lymphoma involving CNS

memory, defect of recent

memory, impairment of

meningeal enhancement

meningismus

mental status, abnormal

mesial temporal lobe

mesial temporal sclerosis

mGlu R5 antibodies

migraine

migraine, children

migraine, pathogenesis

monoclonal antibodies

mortality

Morvan's fibrillary chorea

motor neuron disease

movement disorder

movement disorder, extrapyramidal

movement disorder, psychogenic

MRI

MRI, abdomen

MRI, abnormal

MRI, contrast enhanced

MRI, diffusion weighted

MRI, disappearing lesion on

myasthenia gravis, paraneoplastic

myasthenic syndrome

mycoplasma

mycoplasma pneumoniae

myelitis

myelitis, autoimmune

myelitis, longitudinal

myelitis, transverse, recurrent

neurexin-3 alpha antibodies

neuroendocrinology

neurologic complications

neurologic complications of, systemic cancer

neurologic disease

neurologic disease, diagnoses of

neurologic disease, multifocal

neurologic disease, multiple

neurologic examination, focal

neurologic signs

neuromuscular disease, electrodiagnosis of

neuromuscular junction

neuromyelitis optica (Devic's disease)

neuromyelitis optica, IgG

neuronal cell surface antigen

neuronopathy, sensory

neuroophthalmology

neuropathology

neuropathology, brain

neuropathy, paraneoplastic

neuroprotective agents

NMDA antagonist, late onset

NMDA antagonists

NMDA receptors

noncommunicative

novel cell-membrane antigens

nursing home

nystagmus

nystagmus, upbeating on upgaze

nystagmus, vertical

ocular dipping

ofatumumab

old age, neurology of

olivary degeneration, hypertrophic

onconeural antibodies

opsoclonus-myoclonus syndrome

ovarian tumor

overlap syndrome

pachymeningitis, cranial

paraneoplastic brainstem encephalitis

paraneoplastic cerebellar degeneration

paraspinal muscle

Parkinson disease

Parkinson disease, treatment of

Parkinsonism syndrome

Parkinsonism, freezing phenomena in

paroxysmal neurologic disorder

pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection

peripheral nerve, lesion of

personality change

plasmapheresis

pleocytosis of cerebrospinal fluid

pons, lesion of

post herpes simplex encephalitis immune-mediated relapse

postural abnormality

potassium channel antibodies

practice guidelines

precipitating factors

prevention of neurologic disorders

prognosis

progressive encephalomyelitis with rigidity syndrome

progressive neurologic disorder

psychiatric problems in neurologic disorders

pupil, abnormality in neurologic disorders

Purkinje cell

Purkinje cell surface antibody

pyramidal tract

rabies, nervous system involvement with

rapidly progressing neurologic illness

recurrent

Red flags

release phenomena

remote effect of cancer on the nervous system

research

respirator

retinopathy

reversal of sleep wake cycle

reversible neurologic disorder

salivation, excessive

seizure, drug resistance

seizure, focal

seizure, intractable

seizure, intractable, treatment of

seizure, medication failure

seizure, psychomotor-temporal lobe

seizure, treatment of

seizure, unknown origin

seizure, women

serologic testing

serologic testing of cerebrospinal fluid

serologic testing, false negative

seronegative

seropositive

sexual behavior, disorder of

sleep pathology and physiology

somnolence

spasticity

speech disorder

speech disorder, childhood

spinal cord

spinal cord, cervical

spinal cord, lesion of

standing difficulty

startle reaction

status epilepticus

status epilepticus, nonconvulsive

steroid

steroid responsive encephalopathy

steroid therapy, CNS treatment and complications with

stiff legs

stiff limb syndrome

stiff man syndrome

stiff man syndrome, variant

stress, emotional

striatal encephalitis

striatum, lesion of

striatum, lesion of, bilateral

stroke, progression of

strokelike episodes

sudden death

superior cerebellar peduncle

sweating

sweating, abnormality of

symmetric brain lesions

syphilis, neurologic complications with

tau protein

temporal lobe

temporal lobe, lesion

temporal lobe, lesion, bilateral

thyroid function tests

thyroiditis

thyrotoxicosis

tissue plasminogen activator, intravenous

tone, muscle, increased

tongue, protrusion of

transient ischemic attack

treatment of neurologic disorder

tremor

triangle of Guillain and Mollaret

varicella zoster virus

walking, difficulty with

weight loss

wheelchair

white matter disease

white matter disease, subcortical

wide based gait

workup

Showing articles 600 to 650 of 809 << Previous Next >>

Treatment of Migraine
Lancet 339:1207-1209, Lance,J.W., 1992

Decreased Glutamate Transport by the Brain and Spinal Cord in Amyotrophic Lateral Sclerosis
NEJM 326:1464-1468, 14931992., Rothstein,J.D.,et al, 1992

Chronic Limb-Girdle Myasthenia Gravis
Neurol 42:1153-1156, Oh,S.J.&Kuruoglu,R., 1992

Coronary Vasospasm Induced by Subcutaneous Sumatriptan
BMJ 304:1415, Willett,F.,et al, 1992

Anti-Hu-Associated Pareneoplastic Encephalomyelitis/Sensory Neuronopathy
Medicine 71:59-72, Dalmau,J.,et al, 1992

Dopamine Agonist Treatment of Fluctuating Parkinsonisn
Arch Neurol 49:560-568, Ahlskog,J.E.,et al, 1992

Acute Respiratory Failure from Dopamine Agonist Withdrawal
Neurol 42:1843-1844, Riley,D.E.,et al, 1992

Tardive Dyskinesia Associated with Use of Metoclopramide in a Child
J Pediatr 121:983-985, Putnam,P.E.,et al, 1992

Ranitidine Pharmacokinetics and Adverse Central Nervous System Reactions
Arch Int Med 152:2325-2329, Slugg,P.H.,et al, 1992

Drug-Induced Movement Disorders:An Overview
In Movement Dis in Neurol & Neuropsych, Blackwell Sci Publ, Boston, 2:21., Miller,L.G.&Jankovic,J., 1992

Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992

Extrapyramidal side Effects of Antiemetics Presenting as Psychiatric Illness
Gen Hosp Psychiatry 14:192-195, Rodgers,C., 1992

Myasthenia Gravis in Mothers and Their Newborns
Clin Obstet Gynecol 34:82-99, Plauche,W.C., 1991

Sumatriptan in Migraine, May be Better than Aspirin and Metoclopramide
BMJ 303:1491, Pearce,J.M.S., 1991

Treatment of Acute Migraine with Subcutaneous Sumatriptan
JAMA 265:2831-2835, Cady,R.K.,et al, 1991

Treatment of Migraine Attacks with Sumatriptan
The Subcutaneous Sumatriptan International Study Group, NEJM 325:316-321, 353-354991., , 1991

Migraine Pain Associated with Middle Cerebral Artery Dilatation:Reversal by Sumatriptan
Lancet 338:13-17, Friberg,L.,et al, 1991

Treatment of Acute Cluster Headache with Sumatriptan
The Sumatriptan Cluster Headache Study Group, NEJM 325:322-326, 353-354991., , 1991

Elevated Brain Concentrations of 1, 4-Benzodiazepines in Fulminant Hepatic Failure
NEJM 325:473-478, 5091991., Basile,A.S.,et al, 1991

Neonatal Lupus Erythematosus Simulating Transient Myasthenia Gravis at Presentation
J Pediatr 118:417-419, Rider,L.G.,et al, 1991

Hashimoto's Encephalopathy:A Steroid-Responsive Disorder Associated with High Anti-Thyroid Antibody Titers-Report of 5 Cases
Neurol 41:228-233, Shaw,P.J.,et al, 1991

Diagnosis and Management of Hormone-Secreting Pituitary Adenomas
NEJM 324:822-831, Klibanski,A.&Zervas,N.T., 1991

Central Nervous System Reactions to Histamine-2 Receptor Blockers
Ann Int Med 114:1027-1034, Cantu,T.G.&Korck,J.S., 1991

Oral Sumatriptan in Acute Migraine
Lancet 338:782-783, Goadsby,P.J.,et al, 1991

Magnetic Resonance Imaging of Limbic Encephalitis
Neuroradiology 33:520-523, Kodama,T.,et al, 1991

A Multi-Center, Double-Blind Study on Slow-Release Bromocriptine in the Treatment of Parkinson's Disease
Neurol 41:1598-1602, Mannen,T.,et al, 1991

Pleuropulmonary Disease Associated with Dopamine Agonist Therapy
Ann Neurol 30:613-616, Bhatt,M.H.,et al, 1991

The Apomorphine Test in Parkinsonian Syndromes
JNNP 54:870-872, D'Costa,D.F.,et al, 1991

Paraneoplastic Limbic Encephalitis:Clinicopathological Correlations
JNNP 53:1084-1088, Bakheit,A.M.O.,et al, 1990

Treatment of Prolactin-Secreting Pituitary Macroadenomas with the Long-Acting Non-Ergot Dopamine Agonist CV 205-502
Ann Int Med 112:668-673, Vance,M.L.,et al, 1990

Acromegaly
NEJM 322:966-977, Melmed,S., 1990

Evolution of Brain MRI Abnormalities in Limbic Encephalitis
Neurol 40:1304-1306, Dirr,L.Y.,et al, 1990

Anatomy, Physiology, and Pathology of Epilepsy
lancet 336:231-232, Meldrum,B.S., 1990

Diagnostic Utility of Flumazenil in Coma with Suspected Poisoning:A Double Blind, Randomized Controlled Study
BMJ 301:1308-1311, Hojer,J.,et al, 1990

Limbic Encephalitis Associated with Thymoma
Neurol 40:383, Ingenito,G.G.,et al, 1990

MR Imaging of Paraneoplastic Limbic Encephalitis
J Comput Assist Tomogr 14:115-117, Lacomis,D.,et al, 1990

Bromocriptine-Induced Hypothermia
Neurol 40:383, Pfeiffer,R.F., 1990

Subcutaneous Apomorphine in the Treatment of Parkinson's Disease
JNNP 53:96-101, Frankel,J.P.,et al, 1990

Nasogastric and Intravenous Infusions of (+) -4-propyl-9-hydroxynaphthoxazine (PHNO) in Parkinson's Disease
JNNP 53:102-105, 1990, Coleman,R.J.,et al, 1990

Abnormalities of Striatal Projection Neurons and n-Methyl-d-Aspartate Receptors in Presymptomatic Huntington's Disease
NEJM 322:1293-1298, Albin,R.L.,et al, 1990

Oculogyric Crisis after Metoclopramide Therapy
Optometry and Vision Science 66:179-180, Edward,M.,et al, 1989

Bromocriptine in Parkinson's Disease:A Double-Blind Study Comparing"Low-Slow"and"High-Fast"in de Novo Patients
UK Bromocriptine Res Group, JNNP 52:77-821989., , 1989

Lisuride, A Dopamine Agonist in the Treatment of Early Parkinson's Disease
Neurol 39:336-339, Rinne,U.K., 1989

Pergolide and Selegiline for Parkinson's Disease
The Medical Letter, 31:81-841989., , 1989

Agonist Substitution in Advanced Parkinson's Disease
Neurol 39:1121-1122, Goetz,C.G.,et al, 1989

Physiology & Pharmacology of Dopamine D2-Receptors:Their Implications in Dopamine-Substitute Therapy for Park
Neurol 39:1106-1108, Mercuri,N.B.,et al, 1989

Postmortem Analysis of Adrenal-Medulla-to-Caudate Autograft in a Patient with Parkinson's Disease
Ann Neurol 25:607-614, Hurtig,H.,et al, 1989

The Efficacy of (+) -4-Propyl-9-Hydroxynaphthoxazine as Adjunctive Therapy in Parkinson's Disease
JNNP 52:732-735, Weiner,W.J.,et al, 1989

Neuroleptic Malignant Syndrome, Review of Response to Therapy
Arch Int Med 149:1927-1931, Rosenberg,M.R.&Green,M., 1989

Metoclopramide-Induced Movement Disorders
Arch Int Med 149:2486-2492, Miller,L.G.&Jankovic,J., 1989

Showing articles 600 to 650 of 809 << Previous Next >>